Behbahani Ali's Form 4 filing
CRISPR Therapeutics AG (CRSP) · filed Sep 21, 2026
- Accession no.
- 0001193125-26-396935
- Filed
- Sep 21, 2026, 6:30 PM ET
- Trade date
- Aug 6, 2025
- Filing delay
- 411 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. It was filed 411 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Behbahani AliCIK 0001613867 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | Common Shares | JOtherAcquired | +60 | $0.00 | $0 | 316 | Direct | |
| Aug 6, 2025 | Common Shares | JOtherAcquired | +15 | $0.00 | $0 | 29 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.